0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Retinoids Market Research Report 2024
Published Date: October 2024
|
Report Code: QYRE-Auto-29N18141
Home | Market Reports | Health| Health Conditions
Global Oral Retinoids Market Research Report 2024
BUY CHAPTERS

Global Oral Retinoids Market Research Report 2024

Code: QYRE-Auto-29N18141
Report
October 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Retinoids Market

Oral retinoids are Vitamin A derivatives that are taken systemically to treat a variety of skin conditions and certain types of cancers. They work by regulating cell differentiation and reducing inflammation. The most common conditions treated with oral retinoids include severe acne, psoriasis, and acute promyelocytic leukemia (APL). Some oral retinoids are also used for keratinization disorders and cutaneous T-cell lymphoma.
The global Oral Retinoids market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Oral Retinoids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Retinoids is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Oral Retinoids include Galderma Laboratories, Bausch Health, Actavis, Stiefel Laboratories, GlaxoSmithKline, Dr. Reddy's Laboratories, Barr Pharmaceuticals, Impax Laboratories, Mylan, Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Retinoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Retinoids.
The Oral Retinoids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Oral Retinoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Retinoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Retinoids Market Report

Report Metric Details
Report Name Oral Retinoids Market
Segment by Type
  • Tretinoin
  • Isotretinoin
  • Acitretin
  • Bexarotene
  • Alitretinoin
Segment by Application
  • Hospital and Clinic
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Galderma Laboratories, Bausch Health, Actavis, Stiefel Laboratories, GlaxoSmithKline, Dr. Reddy's Laboratories, Barr Pharmaceuticals, Impax Laboratories, Mylan, Teva, Alembic, Sigmapharm Laboratories, Amneal Pharmaceuticals, Upsher-Smith, Zydus, Par Pharmaceutical, Fuji Pharma, Shandong Liangfu Pharmaceutical, Chongqing Huapont Pharmaceutical, Harbin Dazhong Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Retinoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Retinoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oral Retinoids Market report?

Ans: The main players in the Oral Retinoids Market are Galderma Laboratories, Bausch Health, Actavis, Stiefel Laboratories, GlaxoSmithKline, Dr. Reddy's Laboratories, Barr Pharmaceuticals, Impax Laboratories, Mylan, Teva, Alembic, Sigmapharm Laboratories, Amneal Pharmaceuticals, Upsher-Smith, Zydus, Par Pharmaceutical, Fuji Pharma, Shandong Liangfu Pharmaceutical, Chongqing Huapont Pharmaceutical, Harbin Dazhong Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Heilongjiang Fuhe Pharmaceutical, HEC Pharm

What are the Application segmentation covered in the Oral Retinoids Market report?

Ans: The Applications covered in the Oral Retinoids Market report are Hospital and Clinic, Pharmacy, Other

What are the Type segmentation covered in the Oral Retinoids Market report?

Ans: The Types covered in the Oral Retinoids Market report are Tretinoin, Isotretinoin, Acitretin, Bexarotene, Alitretinoin

1 Oral Retinoids Market Overview
1.1 Product Definition
1.2 Oral Retinoids by Type
1.2.1 Global Oral Retinoids Market Value Comparison by Type (2024-2030)
1.2.2 Tretinoin
1.2.3 Isotretinoin
1.2.4 Acitretin
1.2.5 Bexarotene
1.2.6 Alitretinoin
1.3 Oral Retinoids by Application
1.3.1 Global Oral Retinoids Market Value by Application (2024-2030)
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Retinoids Market Size Estimates and Forecasts
1.4.1 Global Oral Retinoids Revenue 2019-2030
1.4.2 Global Oral Retinoids Sales 2019-2030
1.4.3 Global Oral Retinoids Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Retinoids Market Competition by Manufacturers
2.1 Global Oral Retinoids Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Retinoids Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Retinoids Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Oral Retinoids, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Retinoids, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Retinoids, Product Type & Application
2.7 Global Key Manufacturers of Oral Retinoids, Date of Enter into This Industry
2.8 Global Oral Retinoids Market Competitive Situation and Trends
2.8.1 Global Oral Retinoids Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Retinoids Players Market Share by Revenue
2.8.3 Global Oral Retinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Retinoids Market Scenario by Region
3.1 Global Oral Retinoids Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Retinoids Sales by Region: 2019-2030
3.2.1 Global Oral Retinoids Sales by Region: 2019-2024
3.2.2 Global Oral Retinoids Sales by Region: 2025-2030
3.3 Global Oral Retinoids Revenue by Region: 2019-2030
3.3.1 Global Oral Retinoids Revenue by Region: 2019-2024
3.3.2 Global Oral Retinoids Revenue by Region: 2025-2030
3.4 North America Oral Retinoids Market Facts & Figures by Country
3.4.1 North America Oral Retinoids Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Retinoids Sales by Country (2019-2030)
3.4.3 North America Oral Retinoids Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Retinoids Market Facts & Figures by Country
3.5.1 Europe Oral Retinoids Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Retinoids Sales by Country (2019-2030)
3.5.3 Europe Oral Retinoids Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Retinoids Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Retinoids Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Retinoids Sales by Region (2019-2030)
3.6.3 Asia Pacific Oral Retinoids Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Retinoids Market Facts & Figures by Country
3.7.1 Latin America Oral Retinoids Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Retinoids Sales by Country (2019-2030)
3.7.3 Latin America Oral Retinoids Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Oral Retinoids Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Retinoids Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Retinoids Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Retinoids Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Retinoids Sales by Type (2019-2030)
4.1.1 Global Oral Retinoids Sales by Type (2019-2024)
4.1.2 Global Oral Retinoids Sales by Type (2025-2030)
4.1.3 Global Oral Retinoids Sales Market Share by Type (2019-2030)
4.2 Global Oral Retinoids Revenue by Type (2019-2030)
4.2.1 Global Oral Retinoids Revenue by Type (2019-2024)
4.2.2 Global Oral Retinoids Revenue by Type (2025-2030)
4.2.3 Global Oral Retinoids Revenue Market Share by Type (2019-2030)
4.3 Global Oral Retinoids Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Retinoids Sales by Application (2019-2030)
5.1.1 Global Oral Retinoids Sales by Application (2019-2024)
5.1.2 Global Oral Retinoids Sales by Application (2025-2030)
5.1.3 Global Oral Retinoids Sales Market Share by Application (2019-2030)
5.2 Global Oral Retinoids Revenue by Application (2019-2030)
5.2.1 Global Oral Retinoids Revenue by Application (2019-2024)
5.2.2 Global Oral Retinoids Revenue by Application (2025-2030)
5.2.3 Global Oral Retinoids Revenue Market Share by Application (2019-2030)
5.3 Global Oral Retinoids Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Galderma Laboratories
6.1.1 Galderma Laboratories Company Information
6.1.2 Galderma Laboratories Description and Business Overview
6.1.3 Galderma Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Galderma Laboratories Oral Retinoids Product Portfolio
6.1.5 Galderma Laboratories Recent Developments/Updates
6.2 Bausch Health
6.2.1 Bausch Health Company Information
6.2.2 Bausch Health Description and Business Overview
6.2.3 Bausch Health Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bausch Health Oral Retinoids Product Portfolio
6.2.5 Bausch Health Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Company Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Actavis Oral Retinoids Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Stiefel Laboratories
6.4.1 Stiefel Laboratories Company Information
6.4.2 Stiefel Laboratories Description and Business Overview
6.4.3 Stiefel Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stiefel Laboratories Oral Retinoids Product Portfolio
6.4.5 Stiefel Laboratories Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Oral Retinoids Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Dr. Reddy's Laboratories
6.6.1 Dr. Reddy's Laboratories Company Information
6.6.2 Dr. Reddy's Laboratories Description and Business Overview
6.6.3 Dr. Reddy's Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Dr. Reddy's Laboratories Oral Retinoids Product Portfolio
6.6.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.7 Barr Pharmaceuticals
6.7.1 Barr Pharmaceuticals Company Information
6.7.2 Barr Pharmaceuticals Description and Business Overview
6.7.3 Barr Pharmaceuticals Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Barr Pharmaceuticals Oral Retinoids Product Portfolio
6.7.5 Barr Pharmaceuticals Recent Developments/Updates
6.8 Impax Laboratories
6.8.1 Impax Laboratories Company Information
6.8.2 Impax Laboratories Description and Business Overview
6.8.3 Impax Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Impax Laboratories Oral Retinoids Product Portfolio
6.8.5 Impax Laboratories Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Oral Retinoids Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Teva
6.10.1 Teva Company Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Teva Oral Retinoids Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Alembic
6.11.1 Alembic Company Information
6.11.2 Alembic Description and Business Overview
6.11.3 Alembic Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Alembic Oral Retinoids Product Portfolio
6.11.5 Alembic Recent Developments/Updates
6.12 Sigmapharm Laboratories
6.12.1 Sigmapharm Laboratories Company Information
6.12.2 Sigmapharm Laboratories Description and Business Overview
6.12.3 Sigmapharm Laboratories Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sigmapharm Laboratories Oral Retinoids Product Portfolio
6.12.5 Sigmapharm Laboratories Recent Developments/Updates
6.13 Amneal Pharmaceuticals
6.13.1 Amneal Pharmaceuticals Company Information
6.13.2 Amneal Pharmaceuticals Description and Business Overview
6.13.3 Amneal Pharmaceuticals Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Amneal Pharmaceuticals Oral Retinoids Product Portfolio
6.13.5 Amneal Pharmaceuticals Recent Developments/Updates
6.14 Upsher-Smith
6.14.1 Upsher-Smith Company Information
6.14.2 Upsher-Smith Description and Business Overview
6.14.3 Upsher-Smith Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Upsher-Smith Oral Retinoids Product Portfolio
6.14.5 Upsher-Smith Recent Developments/Updates
6.15 Zydus
6.15.1 Zydus Company Information
6.15.2 Zydus Description and Business Overview
6.15.3 Zydus Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Zydus Oral Retinoids Product Portfolio
6.15.5 Zydus Recent Developments/Updates
6.16 Par Pharmaceutical
6.16.1 Par Pharmaceutical Company Information
6.16.2 Par Pharmaceutical Description and Business Overview
6.16.3 Par Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Par Pharmaceutical Oral Retinoids Product Portfolio
6.16.5 Par Pharmaceutical Recent Developments/Updates
6.17 Fuji Pharma
6.17.1 Fuji Pharma Company Information
6.17.2 Fuji Pharma Description and Business Overview
6.17.3 Fuji Pharma Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Fuji Pharma Oral Retinoids Product Portfolio
6.17.5 Fuji Pharma Recent Developments/Updates
6.18 Shandong Liangfu Pharmaceutical
6.18.1 Shandong Liangfu Pharmaceutical Company Information
6.18.2 Shandong Liangfu Pharmaceutical Description and Business Overview
6.18.3 Shandong Liangfu Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Shandong Liangfu Pharmaceutical Oral Retinoids Product Portfolio
6.18.5 Shandong Liangfu Pharmaceutical Recent Developments/Updates
6.19 Chongqing Huapont Pharmaceutical
6.19.1 Chongqing Huapont Pharmaceutical Company Information
6.19.2 Chongqing Huapont Pharmaceutical Description and Business Overview
6.19.3 Chongqing Huapont Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Chongqing Huapont Pharmaceutical Oral Retinoids Product Portfolio
6.19.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
6.20 Harbin Dazhong Pharmaceutical
6.20.1 Harbin Dazhong Pharmaceutical Company Information
6.20.2 Harbin Dazhong Pharmaceutical Description and Business Overview
6.20.3 Harbin Dazhong Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Harbin Dazhong Pharmaceutical Oral Retinoids Product Portfolio
6.20.5 Harbin Dazhong Pharmaceutical Recent Developments/Updates
6.21 Sichuan Med-Shine Pharmaceutical
6.21.1 Sichuan Med-Shine Pharmaceutical Company Information
6.21.2 Sichuan Med-Shine Pharmaceutical Description and Business Overview
6.21.3 Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Sichuan Med-Shine Pharmaceutical Oral Retinoids Product Portfolio
6.21.5 Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
6.22 Heilongjiang Fuhe Pharmaceutical
6.22.1 Heilongjiang Fuhe Pharmaceutical Company Information
6.22.2 Heilongjiang Fuhe Pharmaceutical Description and Business Overview
6.22.3 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product Portfolio
6.22.5 Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
6.23 HEC Pharm
6.23.1 HEC Pharm Company Information
6.23.2 HEC Pharm Description and Business Overview
6.23.3 HEC Pharm Oral Retinoids Sales, Revenue and Gross Margin (2019-2024)
6.23.4 HEC Pharm Oral Retinoids Product Portfolio
6.23.5 HEC Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Retinoids Industry Chain Analysis
7.2 Oral Retinoids Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Retinoids Production Mode & Process
7.4 Oral Retinoids Sales and Marketing
7.4.1 Oral Retinoids Sales Channels
7.4.2 Oral Retinoids Distributors
7.5 Oral Retinoids Customers
8 Oral Retinoids Market Dynamics
8.1 Oral Retinoids Industry Trends
8.2 Oral Retinoids Market Drivers
8.3 Oral Retinoids Market Challenges
8.4 Oral Retinoids Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Retinoids Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Oral Retinoids Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Oral Retinoids Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Oral Retinoids Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Oral Retinoids Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Oral Retinoids Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Oral Retinoids Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Oral Retinoids Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Oral Retinoids, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Retinoids, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Retinoids, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Retinoids, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Retinoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Retinoids as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Retinoids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Oral Retinoids Sales by Region (2019-2024) & (K Units)
 Table 18. Global Oral Retinoids Sales Market Share by Region (2019-2024)
 Table 19. Global Oral Retinoids Sales by Region (2025-2030) & (K Units)
 Table 20. Global Oral Retinoids Sales Market Share by Region (2025-2030)
 Table 21. Global Oral Retinoids Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Oral Retinoids Revenue Market Share by Region (2019-2024)
 Table 23. Global Oral Retinoids Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Oral Retinoids Revenue Market Share by Region (2025-2030)
 Table 25. North America Oral Retinoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Oral Retinoids Sales by Country (2019-2024) & (K Units)
 Table 27. North America Oral Retinoids Sales by Country (2025-2030) & (K Units)
 Table 28. North America Oral Retinoids Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Oral Retinoids Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Oral Retinoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Oral Retinoids Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Oral Retinoids Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Oral Retinoids Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Oral Retinoids Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Oral Retinoids Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Oral Retinoids Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Oral Retinoids Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Oral Retinoids Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Oral Retinoids Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Oral Retinoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Oral Retinoids Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Oral Retinoids Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Oral Retinoids Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Oral Retinoids Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Oral Retinoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Oral Retinoids Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Oral Retinoids Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Oral Retinoids Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Oral Retinoids Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Oral Retinoids Sales (K Units) by Type (2019-2024)
 Table 51. Global Oral Retinoids Sales (K Units) by Type (2025-2030)
 Table 52. Global Oral Retinoids Sales Market Share by Type (2019-2024)
 Table 53. Global Oral Retinoids Sales Market Share by Type (2025-2030)
 Table 54. Global Oral Retinoids Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Oral Retinoids Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Oral Retinoids Revenue Market Share by Type (2019-2024)
 Table 57. Global Oral Retinoids Revenue Market Share by Type (2025-2030)
 Table 58. Global Oral Retinoids Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Oral Retinoids Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Oral Retinoids Sales (K Units) by Application (2019-2024)
 Table 61. Global Oral Retinoids Sales (K Units) by Application (2025-2030)
 Table 62. Global Oral Retinoids Sales Market Share by Application (2019-2024)
 Table 63. Global Oral Retinoids Sales Market Share by Application (2025-2030)
 Table 64. Global Oral Retinoids Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Oral Retinoids Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Oral Retinoids Revenue Market Share by Application (2019-2024)
 Table 67. Global Oral Retinoids Revenue Market Share by Application (2025-2030)
 Table 68. Global Oral Retinoids Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Oral Retinoids Price (US$/Unit) by Application (2025-2030)
 Table 70. Galderma Laboratories Company Information
 Table 71. Galderma Laboratories Description and Business Overview
 Table 72. Galderma Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Galderma Laboratories Oral Retinoids Product
 Table 74. Galderma Laboratories Recent Developments/Updates
 Table 75. Bausch Health Company Information
 Table 76. Bausch Health Description and Business Overview
 Table 77. Bausch Health Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Bausch Health Oral Retinoids Product
 Table 79. Bausch Health Recent Developments/Updates
 Table 80. Actavis Company Information
 Table 81. Actavis Description and Business Overview
 Table 82. Actavis Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Actavis Oral Retinoids Product
 Table 84. Actavis Recent Developments/Updates
 Table 85. Stiefel Laboratories Company Information
 Table 86. Stiefel Laboratories Description and Business Overview
 Table 87. Stiefel Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Stiefel Laboratories Oral Retinoids Product
 Table 89. Stiefel Laboratories Recent Developments/Updates
 Table 90. GlaxoSmithKline Company Information
 Table 91. GlaxoSmithKline Description and Business Overview
 Table 92. GlaxoSmithKline Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. GlaxoSmithKline Oral Retinoids Product
 Table 94. GlaxoSmithKline Recent Developments/Updates
 Table 95. Dr. Reddy's Laboratories Company Information
 Table 96. Dr. Reddy's Laboratories Description and Business Overview
 Table 97. Dr. Reddy's Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Dr. Reddy's Laboratories Oral Retinoids Product
 Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 100. Barr Pharmaceuticals Company Information
 Table 101. Barr Pharmaceuticals Description and Business Overview
 Table 102. Barr Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Barr Pharmaceuticals Oral Retinoids Product
 Table 104. Barr Pharmaceuticals Recent Developments/Updates
 Table 105. Impax Laboratories Company Information
 Table 106. Impax Laboratories Description and Business Overview
 Table 107. Impax Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Impax Laboratories Oral Retinoids Product
 Table 109. Impax Laboratories Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Mylan Oral Retinoids Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Teva Company Information
 Table 116. Teva Description and Business Overview
 Table 117. Teva Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Teva Oral Retinoids Product
 Table 119. Teva Recent Developments/Updates
 Table 120. Alembic Company Information
 Table 121. Alembic Description and Business Overview
 Table 122. Alembic Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Alembic Oral Retinoids Product
 Table 124. Alembic Recent Developments/Updates
 Table 125. Sigmapharm Laboratories Company Information
 Table 126. Sigmapharm Laboratories Description and Business Overview
 Table 127. Sigmapharm Laboratories Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Sigmapharm Laboratories Oral Retinoids Product
 Table 129. Sigmapharm Laboratories Recent Developments/Updates
 Table 130. Amneal Pharmaceuticals Company Information
 Table 131. Amneal Pharmaceuticals Description and Business Overview
 Table 132. Amneal Pharmaceuticals Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 133. Amneal Pharmaceuticals Oral Retinoids Product
 Table 134. Amneal Pharmaceuticals Recent Developments/Updates
 Table 135. Upsher-Smith Company Information
 Table 136. Upsher-Smith Description and Business Overview
 Table 137. Upsher-Smith Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 138. Upsher-Smith Oral Retinoids Product
 Table 139. Upsher-Smith Recent Developments/Updates
 Table 140. Zydus Company Information
 Table 141. Zydus Description and Business Overview
 Table 142. Zydus Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 143. Zydus Oral Retinoids Product
 Table 144. Zydus Recent Developments/Updates
 Table 145. Par Pharmaceutical Company Information
 Table 146. Par Pharmaceutical Description and Business Overview
 Table 147. Par Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 148. Par Pharmaceutical Oral Retinoids Product
 Table 149. Par Pharmaceutical Recent Developments/Updates
 Table 150. Fuji Pharma Company Information
 Table 151. Fuji Pharma Description and Business Overview
 Table 152. Fuji Pharma Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 153. Fuji Pharma Oral Retinoids Product
 Table 154. Fuji Pharma Recent Developments/Updates
 Table 155. Shandong Liangfu Pharmaceutical Company Information
 Table 156. Shandong Liangfu Pharmaceutical Description and Business Overview
 Table 157. Shandong Liangfu Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 158. Shandong Liangfu Pharmaceutical Oral Retinoids Product
 Table 159. Shandong Liangfu Pharmaceutical Recent Developments/Updates
 Table 160. Chongqing Huapont Pharmaceutical Company Information
 Table 161. Chongqing Huapont Pharmaceutical Description and Business Overview
 Table 162. Chongqing Huapont Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 163. Chongqing Huapont Pharmaceutical Oral Retinoids Product
 Table 164. Chongqing Huapont Pharmaceutical Recent Developments/Updates
 Table 165. Harbin Dazhong Pharmaceutical Company Information
 Table 166. Harbin Dazhong Pharmaceutical Description and Business Overview
 Table 167. Harbin Dazhong Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 168. Harbin Dazhong Pharmaceutical Oral Retinoids Product
 Table 169. Harbin Dazhong Pharmaceutical Recent Developments/Updates
 Table 170. Sichuan Med-Shine Pharmaceutical Company Information
 Table 171. Sichuan Med-Shine Pharmaceutical Description and Business Overview
 Table 172. Sichuan Med-Shine Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 173. Sichuan Med-Shine Pharmaceutical Oral Retinoids Product
 Table 174. Sichuan Med-Shine Pharmaceutical Recent Developments/Updates
 Table 175. Heilongjiang Fuhe Pharmaceutical Company Information
 Table 176. Heilongjiang Fuhe Pharmaceutical Description and Business Overview
 Table 177. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 178. Heilongjiang Fuhe Pharmaceutical Oral Retinoids Product
 Table 179. Heilongjiang Fuhe Pharmaceutical Recent Developments/Updates
 Table 180. HEC Pharm Company Information
 Table 181. HEC Pharm Description and Business Overview
 Table 182. HEC Pharm Oral Retinoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 183. HEC Pharm Oral Retinoids Product
 Table 184. HEC Pharm Recent Developments/Updates
 Table 185. Key Raw Materials Lists
 Table 186. Raw Materials Key Suppliers Lists
 Table 187. Oral Retinoids Distributors List
 Table 188. Oral Retinoids Customers List
 Table 189. Oral Retinoids Market Trends
 Table 190. Oral Retinoids Market Drivers
 Table 191. Oral Retinoids Market Challenges
 Table 192. Oral Retinoids Market Restraints
 Table 193. Research Programs/Design for This Report
 Table 194. Key Data Information from Secondary Sources
 Table 195. Key Data Information from Primary Sources
 Table 196. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Retinoids
 Figure 2. Global Oral Retinoids Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oral Retinoids Market Share by Type: 2023 & 2030
 Figure 4. Tretinoin Product Picture
 Figure 5. Isotretinoin Product Picture
 Figure 6. Acitretin Product Picture
 Figure 7. Bexarotene Product Picture
 Figure 8. Alitretinoin Product Picture
 Figure 9. Global Oral Retinoids Market Value by Application (2024-2030) & (US$ Million)
 Figure 10. Global Oral Retinoids Market Share by Application: 2023 & 2030
 Figure 11. Hospital and Clinic
 Figure 12. Pharmacy
 Figure 13. Other
 Figure 14. Global Oral Retinoids Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global Oral Retinoids Market Size (2019-2030) & (US$ Million)
 Figure 16. Global Oral Retinoids Sales (2019-2030) & (K Units)
 Figure 17. Global Oral Retinoids Average Price (US$/Unit) & (2019-2030)
 Figure 18. Oral Retinoids Report Years Considered
 Figure 19. Oral Retinoids Sales Share by Manufacturers in 2023
 Figure 20. Global Oral Retinoids Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest Oral Retinoids Players: Market Share by Revenue in Oral Retinoids in 2023
 Figure 22. Oral Retinoids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global Oral Retinoids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America Oral Retinoids Sales Market Share by Country (2019-2030)
 Figure 25. North America Oral Retinoids Revenue Market Share by Country (2019-2030)
 Figure 26. United States Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe Oral Retinoids Sales Market Share by Country (2019-2030)
 Figure 29. Europe Oral Retinoids Revenue Market Share by Country (2019-2030)
 Figure 30. Germany Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific Oral Retinoids Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific Oral Retinoids Revenue Market Share by Region (2019-2030)
 Figure 37. China Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America Oral Retinoids Sales Market Share by Country (2019-2030)
 Figure 45. Mexico Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa Oral Retinoids Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa Oral Retinoids Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE Oral Retinoids Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of Oral Retinoids by Type (2019-2030)
 Figure 55. Global Revenue Market Share of Oral Retinoids by Type (2019-2030)
 Figure 56. Global Oral Retinoids Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of Oral Retinoids by Application (2019-2030)
 Figure 58. Global Revenue Market Share of Oral Retinoids by Application (2019-2030)
 Figure 59. Global Oral Retinoids Price (US$/Unit) by Application (2019-2030)
 Figure 60. Oral Retinoids Value Chain
 Figure 61. Oral Retinoids Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Hematologic Malignancies Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-20M14708
Fri Nov 22 00:00:00 UTC 2024

Add to Cart

Add to Cart

Add to Cart

Add to Cart